Vanguard Group Inc. increased its position in Masimo Corp. (NASDAQ:MASI) by 2.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,893,534 shares of the company’s stock after buying an additional 90,732 shares during the period. Vanguard Group Inc. owned about 7.89% of Masimo Corp. worth $204,469,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in MASI. Aperio Group LLC increased its stake in Masimo Corp. by 27.3% in the first quarter. Aperio Group LLC now owns 15,761 shares of the company’s stock valued at $659,000 after buying an additional 3,379 shares during the last quarter. Ngam Advisors L.P. purchased a new position in Masimo Corp. during the first quarter worth about $461,000. Menta Capital LLC increased its position in Masimo Corp. by 23.5% in the first quarter. Menta Capital LLC now owns 22,100 shares of the company’s stock worth $925,000 after buying an additional 4,200 shares in the last quarter. Spark Investment Management LLC purchased a new position in Masimo Corp. during the first quarter worth about $2,092,000. Finally, Zebra Capital Management LLC increased its position in Masimo Corp. by 20.9% in the first quarter. Zebra Capital Management LLC now owns 21,916 shares of the company’s stock worth $917,000 after buying an additional 3,783 shares in the last quarter. 79.86% of the stock is owned by institutional investors.
Masimo Corp. (NASDAQ:MASI) opened at 58.44 on Monday. The stock has a market capitalization of $2.88 billion, a P/E ratio of 30.64 and a beta of 0.70. Masimo Corp. has a one year low of $33.03 and a one year high of $60.81. The company has a 50 day moving average of $59.22 and a 200-day moving average of $52.07.
Masimo Corp. (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.16. The business earned $172.64 million during the quarter, compared to the consensus estimate of $166.02 million. Masimo Corp. had a return on equity of 29.07% and a net margin of 15.40%. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.36 earnings per share. Equities research analysts predict that Masimo Corp. will post $2.02 earnings per share for the current fiscal year.
A number of equities analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Masimo Corp. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 4th. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $55.00 price objective (up from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. BTIG Research reaffirmed a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. Finally, Wedbush reaffirmed an “outperform” rating and set a $63.00 price objective (up from $60.00) on shares of Masimo Corp. in a report on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $52.60.
In other news, CEO Joe E. Kiani sold 84,617 shares of Masimo Corp. stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $60.26, for a total value of $5,099,020.42. Following the completion of the transaction, the chief executive officer now owns 126,450 shares in the company, valued at approximately $7,619,877. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Rick Fishel sold 22,000 shares of Masimo Corp. stock in a transaction that occurred on Wednesday, July 20th. The stock was sold at an average price of $53.85, for a total value of $1,184,700.00. Following the completion of the transaction, the insider now owns 42,022 shares of the company’s stock, valued at approximately $2,262,884.70. The disclosure for this sale can be found here. 16.60% of the stock is owned by company insiders.
Masimo Corp. Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.